BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27608320)

  • 1. Can we use plasma hyperosmolality as a predictor of mortality for ST-segment elevation myocardial infarction?
    Tatlisu MA; Kaya A; Keskin M; Uzman O; Borklu EB; Cinier G; Hayiroglu MI; Tatlisu K; Eren M
    Coron Artery Dis; 2017 Jan; 28(1):70-76. PubMed ID: 27608320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
    Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
    Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of the coronary thrombus burden with all-cause mortality and major cardiac events in ST-segment elevation myocardial infarction patients treated with tirofiban.
    Tatlisu MA; Kaya A; Keskin M; Uzman O; Borklu EB; Cinier G; Hayiroglu MI; Eren M
    Coron Artery Dis; 2016 Nov; 27(7):543-50. PubMed ID: 27341666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
    Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
    Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.
    Yamashita Y; Shiomi H; Morimoto T; Yaku H; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Abe M; Nagao K; Shizuta S; Ono K; Kimura T;
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28073848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High cystatin C levels predict long-term mortality in patients with ST-segment elevation myocardial infarction undergoing late percutaneous coronary intervention: A retrospective study.
    Chen Y; Fan Y; Men M; Shen G; Ma A
    Clin Cardiol; 2019 May; 42(5):572-578. PubMed ID: 30907012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI.
    Çiçek G; Kundi H; Bozbay M; Yayla C; Uyarel H
    Coron Artery Dis; 2016 May; 27(3):176-84. PubMed ID: 26751423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Wanamaker BL; Seth MM; Sukul D; Dixon SR; Bhatt DL; Madder RD; Rumsfeld JS; Gurm HS
    J Am Heart Assoc; 2019 Oct; 8(19):e013551. PubMed ID: 31547767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
    Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention.
    Hemradj VV; Ottervanger JP; van 't Hof AW; Dambrink JH; Gosselink M; Kedhi E; Suryapranata H;
    Clin Cardiol; 2016 Nov; 39(11):665-669. PubMed ID: 27775864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
    Çınar T; Çağdaş M; Rencüzoğulları İ; Karakoyun S; Karabağ Y; Yesin M; Sadioğlu Çağdaş Ö; Tanboğa Hİ
    Scand Cardiovasc J; 2019 Apr; 53(2):83-90. PubMed ID: 30835559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel and useful predictive indicator of prognosis in ST-segment elevation myocardial infarction, the prognostic nutritional index.
    Keskin M; Hayıroğlu MI; Keskin T; Kaya A; Tatlısu MA; Altay S; Uzun AO; Börklü EB; Güvenç TS; Avcı II; Kozan Ö
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):438-446. PubMed ID: 28392077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
    Kahlon TS; Barn K; Akram MM; Blankenship JC; Bower-Stout C; Carey DJ; Sun H; Tompkins Weber K; Skelding KA; Scott TD; Green SM; Berger PB
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):245-251. PubMed ID: 27142567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of rising mean platelet volume during hospitalization in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Avci E; Kiris T; Çelik A; Variş E; Esin FK; Köprülü D; Kadi H
    BMC Cardiovasc Disord; 2018 Dec; 18(1):226. PubMed ID: 30526502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes in Young Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.
    Gao M; Zhao W; Zhang Z; Qin L; Zhang W; Zheng Y
    Am J Med Sci; 2018 Jun; 355(6):544-552. PubMed ID: 29891037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.